Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
Use of left atrial venoarterial cannulation during extracorporeal membrane oxygenation—a technique known as LAVA ECMO—appears to be a safe and feasible means of support for patients with cardiogenic ...
The current trend of using two cannulas to place most newborns in respiratory failure on life-sustaining ECMO, one in the right internal jugular vein and a second in the right common carotid artery, ...
Extracorporeal membrane oxygenation (ECMO) is a method of providing lung and heart support to patients with inadequate blood perfusion in the body, or gas exchange in the lungs. Blood is pumped from ...
The global arterial cannula market is witnessing steady expansion and is projected to grow at a CAGR of approximately 7% during the forecast period, supported by the rising prevalence of ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results